BioCentury
ARTICLE | Company News

Dyax, AstraZeneca deal

August 31, 2009 7:00 AM UTC

Dyax will receive an undisclosed milestone payment from AstraZeneca's MedImmune Inc. subsidiary under a 2003 deal granting MedImmune a non-exclusive license to Dyax's antibody phage display libraries....